Educational Intervention for Hypertension Management

September 10, 2021 updated by: Prof. Dr. Tariq Ashraf, University of Karachi

Impact of Educational Intervention on Hypertension Management by Primary Care Physician (Pump)

An interventional study is designed and a structured educational session will be conducted regarding the management of Blood pressure for the general physicians of Karachi, Lahore, Peshawar, Islamabad, Multan and Quetta. The purpose of designing this study is to observe the effect of hypertension educational intervention for general physicians to improve patient outcomes indirectly. Results of this study may provide a basis for developing a hypertension educational program targeted at general physicians.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Study Procedure

  1. Screening of General physicians as per inclusion criteria and recruitment of GPs by clinical research associate after obtaining informed consent form.
  2. GPs will be asked to fill hypertension awareness questionnaire at baseline
  3. Both group of GPs with the help of clinical research associate will recruit 5 patients from study site.
  4. After obtaining informed consent, Patient will be asked to fill hypertension awareness questionnaire at baseline or recruitment day and share pictures of 12-hour blood pressure measurement (from digital BP apparatus) with clinical research associate.
  5. Randomization of GPs will be than in to 2 Groups.
  6. After randomization, Group 1 GPs will receive (1 day) face to face education and Group 2 GPs will receive print version of education material.
  7. After GPs education intervention, patients will be invited for regular checkup at GPs clinic.
  8. Patient will be again asked to fill hypertension awareness questionnaire after 3 months and share pictures of 12-hour blood pressure measurement (from digital BP apparatus) with clinical research associate. (1st, 2nd & 3rd Month).
  9. GPs will be asked to fill hypertension awareness questionnaire again after 3 months (Post intervention)

Study Type

Interventional

Enrollment (Anticipated)

126

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Sindh
      • Karachi, Sindh, Pakistan, 78500
        • Karachi institute of heart disease
        • Contact:
          • Tariq Ashraf, FCPS
          • Phone Number: 03222999914

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • GPs who have at least three years of practice experience in the broad disciplines of primary care using the Numerical Pain Rating (NPR) scale over the past week ≥ 2 on a 0-10 numerical pain scale.
  • Patients between 18-60 years.
  • Patients with uncontrolled blood pressure according to Pakistan hypertension league guidelines
  • Patients with or without angiographically proven coronary, peripheral or cerebral vascular disease.
  • Patients must be able to give informed consent and be able to read and comprehend in the Urdu (National Language)
  • Patients must have a digital BP apparatus at home.
  • Patients must have a phone with camera and internet.

Exclusion Criteria:

  • GPs who had attended a planned Hypertension educational program during the last 6 months.
  • Patients with a recognized psychiatric disorder as per the Diagnostic and Statistical Manual of Mental Disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interventional group
GPs of the Interventional group will receive (1 day) face to face education with structured educational material on strategies of hypertension management by a senior cardiologist.
  1. Key points of current hypertension guidelines.
  2. 10-step checklist how to obtain standardized upper arm blood pressure readings according to guidelines.
  3. template of a blood pressure documentation sheet for serial documentation of blood pressure values by patients.
  4. checklists to assist in the diagnosis of secondary hypertension.
  5. Patient information leaflet about hypertension.
Active Comparator: Control group
GPs of the Control group will receive print version of education material (Structured educational material) on strategies of structured hypertension management.
  1. Key points of current hypertension guidelines.
  2. 10-step checklist how to obtain standardized upper arm blood pressure readings according to guidelines.
  3. template of a blood pressure documentation sheet for serial documentation of blood pressure values by patients.
  4. checklists to assist in the diagnosis of secondary hypertension.
  5. Patient information leaflet about hypertension.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood Pressure
Time Frame: 3 Months
Pre & Post change in the blood pressure control rate. Defined as percentage of patients with an average 12-hour blood pressure <130/80 mmHg.
3 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge of GPs about Hypertension Management
Time Frame: 3 Months
Pre & Post knowledge enhancement of GPs regarding hypertension management.
3 Months
Knowledge of Patients about Hypertension Management
Time Frame: 3 Months
Pre & Post knowledge enhancement of patients regarding hypertension
3 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 30, 2021

Primary Completion (Anticipated)

December 31, 2022

Study Completion (Anticipated)

December 31, 2022

Study Registration Dates

First Submitted

August 22, 2021

First Submitted That Met QC Criteria

September 2, 2021

First Posted (Actual)

September 9, 2021

Study Record Updates

Last Update Posted (Actual)

September 17, 2021

Last Update Submitted That Met QC Criteria

September 10, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Face to face Educational Training

Subscribe